A Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 as Monotherapy and Combination Therapy in Subjects With BRAF V600 Mutant Solid Tumors

Clinical trial NCT05668585 · COMPLETED

Trial details

NCT number: NCT05668585
Sponsor: C4 Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumors Melanoma NSCLC CRC ATC

Start date: 2022-12-08
Primary completion: 2025-11-05
Enrollment: 89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.